Lv1
40 积分 2025-10-04 加入
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma
16天前
已完结
Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer
16天前
已完结
Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer
2个月前
已完结
甲状腺未分化癌诊疗专家共识2023
3个月前
已完结
甲状旁腺癌5例并文献复习
5个月前
已完结
Malignant struma ovarii: Advances in molecular pathogenesis, classification, diagnosis and treatment
6个月前
已完结
Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway
6个月前
已完结
The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH1 Expression and Targeting Tumor-Initiating Cells
6个月前
已完结
CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells
7个月前
已完结
Malignant Struma Ovarii with Thyrotoxicosis
8个月前
已完结
皖公网安备34019202002308
